Stage FocusPre-Seed, Seed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Longwood Fund manages $650M+ in total AUM, with Fund VI closing at $180M as their largest fund to date. The track record is exceptional for biotech company creation: partners have co-founded approximately 25 companies with 20+ launched and marketed drugs and therapies. Portfolio companies include GRAIL, BridgeBio, and PTC Therapeutics, alongside clinical-stage assets, with 10 IPOs and 8 acquisitio...
Notable Investments
G
GRAILB
BridgeBioP
PTC TherapeuticsA
AcceleronA
AlnylamV
VertexSimilar Funds
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
IV
Illinois Ventures
Champaign, Illinois, United States
Pure DeepTechBiotechAIQuantumPre-SeedSeed
MC
MBX Capital
New York, United States
Pure DeepTechBiotechMedtechRoboticsPre-SeedSeed
PS
Panacea Stars
Oxford, United Kingdom
Pure DeepTechBiotechAIMedtechPre-SeedSeed
RG
R42 Group
Stanford, California, United States
Pure DeepTechBiotechAIMedtechPre-SeedSeed
AC
Actions Capital
New York, United States
GeneralistBiotechRoboticsMedtechPre-SeedSeed